Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Jan;29(1):21-8. doi: 10.1007/s00380-013-0325-2. Epub 2013 Feb 21.

2.

Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Mar;29(2):156-64. doi: 10.1007/s00380-013-0339-9. Epub 2013 Apr 4.

3.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
4.

Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).

Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF.

Am J Cardiol. 2014 Feb 15;113(4):621-5. doi: 10.1016/j.amjcard.2013.11.006. Epub 2013 Nov 23.

PMID:
24342762
5.

Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.

Miao Y, Yu-Jie Z, Zhi-Jian W, Dong-Mei S, Yu-Yang L, Ying-Xin Z, Fei G, Shi-Wei Y, De-An J.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):361-7. doi: 10.1002/ccd.23464. Epub 2012 Mar 14.

PMID:
22419375
6.

Long-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Jul;29(4):437-42. doi: 10.1007/s00380-013-0382-6. Epub 2013 Jun 27.

7.

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.

Tazaki J, Morimoto T, Sakata R, Okabayashi H, Yamazaki F, Nishiwaki N, Mitsudo K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

J Vasc Surg. 2014 Sep;60(3):604-12.e2. doi: 10.1016/j.jvs.2014.03.280. Epub 2014 May 3.

8.

Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease.

Kinoshita T, Asai T, Suzuki T.

J Thorac Cardiovasc Surg. 2015 Aug;150(2):315-21.e3. doi: 10.1016/j.jtcvs.2015.04.058. Epub 2015 May 9.

9.

Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.

Sai E, Shimada K, Miyauchi K, Masaki Y, Kojima T, Miyazaki T, Kurata T, Ogita M, Tsuboi S, Yoshihara T, Miyazaki T, Ohsaka A, Daida H.

Heart Vessels. 2016 May;31(5):694-701. doi: 10.1007/s00380-015-0674-0. Epub 2015 Apr 12.

PMID:
25863806
10.

Recent characteristics and outcomes of Japanese stable angina pectoris after percutaneous coronary intervention. An observational cohort study using the Shinken Database.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Int Heart J. 2013;54(6):335-40.

11.

Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Natsuaki M, Furukawa Y, Morimoto T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2012 Dec 1;110(11):1568-77. doi: 10.1016/j.amjcard.2012.07.021. Epub 2012 Aug 28.

PMID:
22935527
12.

The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.

Athyros VG, Tziomalos K, Katsiki N, Gossios TD, Giouleme O, Anagnostis P, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP; GREACE Study Collaborative Group.

Curr Vasc Pharmacol. 2013 Sep;11(5):779-84.

PMID:
23140546
13.
14.

Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).

Ota T, Ishii H, Suzuki S, Shibata Y, Tatami Y, Harata S, Shimbo Y, Takayama Y, Tanaka A, Kawamura Y, Osugi N, Maeda K, Kondo T, Murohara T.

Atherosclerosis. 2015 Sep;242(1):155-60. doi: 10.1016/j.atherosclerosis.2015.07.012. Epub 2015 Jul 9.

PMID:
26188539
15.

Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.

Ndrepepa G, Braun S, Tada T, Guerra E, Schunkert H, Laugwitz KL, Kastrati A.

Cardiovasc Revasc Med. 2014 Apr;15(3):131-6. doi: 10.1016/j.carrev.2014.02.003. Epub 2014 Mar 2.

PMID:
24630704
16.

Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.

Wada H, Ogita M, Miyauchi K, Shitara J, Endo H, Doi S, Naito R, Konishi H, Tsuboi S, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Suwa S, Daida H.

Heart Vessels. 2017 Jan;32(1):16-21. doi: 10.1007/s00380-016-0835-9. Epub 2016 Apr 23.

PMID:
27107767
17.

Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.

Chaikriangkrai K, Nabi F, Mahmarian JJ, Chang SM.

Int J Cardiovasc Imaging. 2015 Dec;31(8):1619-26. doi: 10.1007/s10554-015-0732-9. Epub 2015 Aug 5.

PMID:
26243534
18.

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.

Zhang X, Xiang C, Zhou YH, Jiang A, Qin YY, He J.

BMC Cardiovasc Disord. 2014 Feb 17;14:19. doi: 10.1186/1471-2261-14-19. Review.

19.

Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I; TRUTH INVESTIGATORS.

Nephrology (Carlton). 2012 Sep;17(7):628-35. doi: 10.1111/j.1440-1797.2012.01628.x.

PMID:
22708952
20.

Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients.

Kai H, Ueno T, Kimura T, Adachi H, Furukawa Y, Kita T, Imaizumi T; CREDO-Kyoto Investigators.

J Hypertens. 2011 Oct;29(10):1889-96. doi: 10.1097/HJH.0b013e32834a5a67.

PMID:
21857536

Supplemental Content

Support Center